Please use this identifier to cite or link to this item:
|Title:||A systematic review of ileal conduit and neobladder outcomes in primary bladder cancer|
|Authors:||Crozier, Jack;Hennessey, Derek;Sengupta, Shomik;Bolton, Damien M;Lawrentschuk, Nathan L|
|Citation:||Urology 2016; online first: 29 June|
|Abstract:||Treatment for muscle invasive bladder cancer with curative intent includes radical cystectomy and urinary diversion. Using PRISMA guidelines, we conducted a systematic review assessing differences in patient selection, operative parameters, complications, and quality of life between ileal conduit and neobladder cohorts. Ileal conduit cohorts have more advanced age and disease, more comorbidities and complications, and poorer quality of life. Ileal conduit surgery is associated with adverse patient selection that inhibits reasonable comparison of outcomes with neobladder cohorts. Despite this, we observe longer operative times and hospital stays in neobladder cohorts, perhaps reflecting greater technical difficulty and the need for postoperative bladder training.|
|Type of Clinical Study or Trial:||Reviews/Systematic Reviews|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.